CHEPLAPHARM Group Implements AI-Driven Supply Chain Transformation

CHEPLAPHARM Group, a German pharmaceutical company, has integrated with TraceLink's Multienterprise Information Network Tower (MINT) to enhance its supply chain operations. This transition aims to standardize and automate processes previously managed through manual methods, such as emails and non-standard documents. The new system will allow for real-time visibility and agility in operations, significantly reducing administrative workload. A key feature of this integration is the B2N Integrate-Once™ model, which facilitates rapid partner onboarding without costs for partners. This approach aims to streamline digital transactions and reduce IT complexity. The initiative is expected to improve operational resilience and data integrity across CHEPLAPHARM's global network. The integration is now live as of May 17, 2026.

Key Points: • CHEPLAPHARM has launched its integration with TraceLink for supply chain automation. • The B2N Integrate-Once™ model allows partners to onboard without costs. • The initiative aims to reduce manual workflows and improve operational efficiency.